Jan 08, 2024
1:30
For every 30 shares held, investors received 1. The price per share adjusted from $0.24 to $0.01.
The split itself did not change the total investment value.
Eiger BioPharmaceuticals, Inc. (EIGRQ) trades on the Other OTC in the Biotechnology industry.
Eiger BioPharmaceuticals, Inc. company overviewThe latest split shown was on January 8, 2024. It was a 1-for-30 reverse split, so shareholders received 1 share for every 30 they held.
This history records 2 reverse splits between March 23, 2016 and January 8, 2024.